<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Dyhr Malling | Activity</title>
	<link>https://recash.wpsoul.net/members/runpeen90/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/runpeen90/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Dyhr Malling.</description>
	<lastBuildDate>Fri, 07 Aug 2026 10:43:14 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bfda2404ab80af0a37da60f8d4fa241b</guid>
				<title>Dyhr Malling posted an update: The most common adverse event was somnolence (n = 7 pat [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/170478/</link>
				<pubDate>Tue, 14 Jan 2025 14:30:08 +0000</pubDate>

									<content:encoded><![CDATA[<p>The most common adverse event was somnolence (n = 7 patients, 17.5%). All adverse events were grade 1. Thirty-six patients were included in the exploratory analysis of efficacy. No patients experienced vomiting during the first 120 h after chemotherapy, and complete response and complete control were both 86.1%. The rate of total control was 55.&hellip;<span class="activity-read-more" id="activity-read-more-170478"><a href="https://recash.wpsoul.net/activity/p/170478/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e5fbf6f2c786104d880d8273f2c74cea</guid>
				<title>Dyhr Malling posted an update: 06 ± 1.06 D at 35° temporal visual field WC. All Proclear m [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/160460/</link>
				<pubDate>Thu, 09 Jan 2025 13:50:47 +0000</pubDate>

									<content:encoded><![CDATA[<p>06 ± 1.06 D at 35° temporal visual field WC. All Proclear multifocal contact lenses (MFCLs) decreased the peripheral hyperopic defocus with increasing addition powers (F [2.938, 47.001] = 13.317, </p>
<p> &lt; 0.001). <a href="https://www.selleckchem.com/products/Trichostatin-A.html" rel="nofollow ugc">Trichostatin A nmr</a> However, only +3.00 D addition and +3.50 D addition (</p>
<p> = 0.001) could invert the peripheral hyperopic defocus into p&hellip;<span class="activity-read-more" id="activity-read-more-160460"><a href="https://recash.wpsoul.net/activity/p/160460/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">51ba7e756ee541ac67dac319b0de0afc</guid>
				<title>Dyhr Malling posted an update: reast CSCs in vitro. Thus TQ together with anti-angiogenic [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/154838/</link>
				<pubDate>Tue, 07 Jan 2025 13:07:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>reast CSCs in vitro. Thus TQ together with anti-angiogenic therapies may be a novel therapeutic agent in the suppression of VM in breast cancer.</p>
<p>TQ could alter the vasculogenic capacity and mesenchymal-epithelial transition of human breast CSCs in vitro. Thus TQ together with anti-angiogenic therapies may be a novel therapeutic agent in the&hellip;<span class="activity-read-more" id="activity-read-more-154838"><a href="https://recash.wpsoul.net/activity/p/154838/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">475f7b6d0b1bd485cd9a33b8fd88cd6f</guid>
				<title>Dyhr Malling posted an update: This study aimed to investigate the effectiveness of [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/151673/</link>
				<pubDate>Mon, 06 Jan 2025 13:21:30 +0000</pubDate>

									<content:encoded><![CDATA[<p>This study aimed to investigate the effectiveness of solution-oriented intervention in patients with gestational diabetes, stress and anxiety on using coping strategies. This study was a randomized clinical trial with a control group. The population consisted of 56 diabetic women under treatment with insulin, who obtained higher score in one of&hellip;<span class="activity-read-more" id="activity-read-more-151673"><a href="https://recash.wpsoul.net/activity/p/151673/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ff66e3767aad88be924d3f58720c226f</guid>
				<title>Dyhr Malling posted an update: Inequity in healthcare use is avoidable inequality, and it [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/147691/</link>
				<pubDate>Sun, 05 Jan 2025 20:13:55 +0000</pubDate>

									<content:encoded><![CDATA[<p>Inequity in healthcare use is avoidable inequality, and it exists when there are differences in the use of healthcare after standardization of different needs among the population. In Ethiopia, wide variation and lower achievement exists in outpatient visit per person per year against the target to reach by 2020. Therefore, this study is aimed at&hellip;<span class="activity-read-more" id="activity-read-more-147691"><a href="https://recash.wpsoul.net/activity/p/147691/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b96fb031061201c2a4bcee86ce9f276e</guid>
				<title>Dyhr Malling became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/147567/</link>
				<pubDate>Sun, 05 Jan 2025 19:41:31 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>